European Commission logo
English English
CORDIS - EU research results
Content archived on 2024-05-29

Identification and characterization of the sAPP receptor(s)


Amyloid precursor protein (APP) is genetically and biochemically linked to the pathogenesis of Alzheimer¿s disease (AD), the most common cause of senile dementia in industrialized countries. It has been proposed that reduction of the level or activity of c ertain APP fragments, in addition to accumulation of Abeta peptide, may play a critical role in the cognitive dysfunction associated with AD. To test this hypothesis, it is important to understand the roles that full-length APP and its fragments normally p lay in neuronal structure and function. Emerging evidence suggests that sAPP, the secreted N-terminal fragment of APP, can be considered as a signaling polypeptide that evokes coordinated responses in neuronal and some non-neuronal target cells. Prerequisi te for such functions is the existence of a membrane receptor for sAPP, which has been postulated but is at present unidentified. The aim of the proposed study is to identify sAPP receptors and characterize them biochemically. For this purpose, binding stu dies with recombinant sAPP will be performed with sections of brain and other tissues. In addition, the results of the tissue-binding approach will be confirmed by conducting binding studies with cultured cells. To be able to analyze the complex of sAPP wi th its receptor, the complex will be covalently linked via the photocrosslinking amino acid p-benzoyl-L.phenylalanine. Introduction of the photolabile amino acid at defined positions ensures that only direct binding partners are stably bound. Thereafter, t he complex will be purified and sAPP-bound proteins will be characterized by mass-spectrometrical methods.

Call for proposal

See other projects for this call


EU contribution
No data
Rijvisschestraat 120

See on map

Total cost
No data